.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Dow
Harvard Business School
Medtronic
Queensland Health
Merck
Johnson and Johnson
Boehringer Ingelheim
Express Scripts
QuintilesIMS

Generated: September 25, 2017

DrugPatentWatch Database Preview

TEXACORT Drug Profile

« Back to Dashboard

What is the patent landscape for Texacort, and when can generic versions of Texacort launch?

Texacort is a drug marketed by Mission Pharma and is included in two NDAs.

The generic ingredient in TEXACORT is hydrocortisone. There are sixty drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.

Summary for Tradename: TEXACORT

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list55
Patent Applications: see list9,813
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TEXACORT at DailyMed

Pharmacology for Tradename: TEXACORT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mission Pharma
TEXACORT
hydrocortisone
SOLUTION;TOPICAL080425-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mission Pharma
TEXACORT
hydrocortisone
SOLUTION;TOPICAL081271-001Apr 17, 1992RXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
UBS
Julphar
AstraZeneca
Chinese Patent Office
Cerilliant
Farmers Insurance
Boehringer Ingelheim
Mallinckrodt
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot